4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-026672
Chief Financial Officer acquired 19,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Horn Howard Chief Financial Officer | 2024-03-01 | Grant or award | +19,400 | 99,766 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Horn Howard Chief Financial Officer | 2024-03-01 | Grant or award · Stock Option (Right to Buy) | +34,200 | 34,200 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…